Suppr超能文献

加纳博诺地区存在持续感染的盘尾丝虫病流行社区中,依维菌素治疗不依从:一项混合方法研究。

Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study.

机构信息

Centre for Research in Applied Biology, School of Sciences, University of Energy and Natural Resources, Sunyani, Bono Region, Ghana.

Department of Biological Science, School of Sciences, University of Energy and Natural Resources, Sunyani, Bono Region, Ghana.

出版信息

BMC Infect Dis. 2023 Nov 16;23(1):805. doi: 10.1186/s12879-023-08806-8.

Abstract

BACKGROUND

The World Health Organization has proposed that onchocerciasis elimination (interruption) of transmission be verified in 12 (approximately a third) endemic countries by 2030. The strategy to reach this goal is based on ivermectin Mass Drug Administration (MDA) with high geographical and therapeutic coverage. In addition to coverage, high levels of treatment adherence are paramount. We investigated factors associated with ivermectin intake in an area of Ghana with persistent Onchocerca volvulus infection.

METHODS

In August 2021, a cross-sectional mixed-methods study was conducted in 13 onchocerciasis-endemic communities in the Bono Region of Ghana. Individuals aged ≥ 10 years were invited to participate in a questionnaire survey. A total of 48 focus group discussions and in-depth interviews with 10 community drug distributors and 13 community leaders were conducted.

RESULTS

A total of 510 people participated in the study [median age: 32, interquartile range 30 (20‒50) years]; 274 (53.7%) were females. Of the total, 320 (62.7%) declared that they adhered to each treatment round and 190 (37.3%) admitted they had not taken ivermectin during at least one MDA round, since becoming eligible for treatment. Of 483 participants with complete information, 139 (28.8%) did not take ivermectin during the last round (March 2021), and 24 (5.0%) had never taken ivermectin (systematic non-adherers). Reasons for not taking ivermectin included previous experience/fear of side-effects, being absent during MDA, pregnancy, the desire to drink alcohol, and drug distribution challenges. Being male, having good knowledge and perception of the disease, and not having secondary or higher level of formal education were significantly associated with higher odds of ivermectin intake.

CONCLUSIONS

A relatively high level of non-adherence to ivermectin treatment was documented. There is a need for targeted educational and behavioural change campaigns to reverse these trends and ensure a steady course toward meeting onchocerciasis elimination targets in Ghana.

摘要

背景

世界卫生组织提出,到 2030 年,在 12 个(约三分之一)流行国家验证消灭(阻断)盘尾丝虫病的传播。实现这一目标的策略是基于伊维菌素大规模药物治疗(MDA),具有高的地理和治疗覆盖率。除了覆盖率之外,高水平的治疗依从性至关重要。我们调查了在加纳一个持续存在盘尾丝虫感染的地区与伊维菌素摄入相关的因素。

方法

2021 年 8 月,在加纳博诺地区的 13 个盘尾丝虫病流行社区进行了一项横断面混合方法研究。邀请年龄≥10 岁的个人参加问卷调查。共进行了 48 次焦点小组讨论和 10 次社区药物分发人员以及 13 次社区领导的深入访谈。

结果

共有 510 人参加了这项研究[中位数年龄:32 岁,四分位间距 30(20-50)岁];274 人(53.7%)为女性。在总人数中,320 人(62.7%)宣称他们遵守了每一轮治疗,190 人(37.3%)承认他们至少有一轮 MDA 期间没有服用伊维菌素,因为他们有资格接受治疗。在 483 名有完整信息的参与者中,有 139 人(28.8%)在上一轮(2021 年 3 月)没有服用伊维菌素,24 人(5.0%)从未服用过伊维菌素(系统不依从者)。未服用伊维菌素的原因包括以前的经验/对副作用的恐惧、在 MDA 期间缺席、怀孕、想喝酒以及药物分发方面的挑战。男性、对疾病有良好的知识和认知、没有中等或高等程度的正规教育,与服用伊维菌素的几率较高显著相关。

结论

记录到相当高的伊维菌素治疗不依从率。需要有针对性的教育和行为改变运动,以扭转这些趋势,并确保加纳在实现消灭盘尾丝虫病目标的道路上稳步前进。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1c/10655298/6256b0db2dcb/12879_2023_8806_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验